A watchdog says crisis pregnancy centers are advertising they can "rule out" ectopic pregnancy after a single scan. Medical groups say diagnosis usually requires follow‑up testing.

A UNSW‑led review published in Carcinogenesis finds e‑cigarettes "likely" carcinogenic; U.S. health agencies and experts are weighing the evidence.

A Pittsburgh verdict has thrust the unregulated delta‑8 THC market into the spotlight as health officials warn of contaminants and adverse reactions.

Listening to Mothers IV finds Medicaid-covered birthing people report delayed prenatal care, higher complication rates, and widespread feelings of being ignored.

The FDA says Inventia-made chlorthalidone 25 mg failed dissolution testing; two lots — 11,460 bottles — were recalled nationwide. Patients should consult their pharmacist before changing therapy.

A Psychological Bulletin review of 307 studies finds rising perfectionism among college students, with sharp increases in worry over mistakes and socially prescribed pressure.

Starting July 1, 2026, Medicare’s GLP‑1 Bridge will let select Part D enrollees get Wegovy, Zepbound or Foundayo for $50 a month — but strict BMI and health rules apply.

A University of Georgia meta‑analysis found tirzepatide produced the largest weight loss among GLP‑1 therapies in non‑diabetic adults, but questions remain on durability and access.

UNLV researchers were among co‑authors of a GBD study published in Med that finds the U.S. had the highest substance use disorder prevalence in 2023 and projects increases to 2050 without intervention.

A national ABCD study finds early heavy social media use tied to much higher odds that teens will try alcohol, nicotine and cannabis.

Unregulated injectable peptides marketed online are rising among teens and young men in DC, prompting warnings from doctors and federal regulators. Clinicians and the FDA say the risks go beyond marketing claims.

Certain duloxetine (generic Cymbalta) lots were recalled after tests found a nitrosamine impurity; regulators and pharmacists advise checking NDCs and talking to your prescriber.

A biomarker analysis of more than 30,000 adults found that most people who meet the 'five-a-day' guideline still fall short of the 500 mg/day flavanol level linked to lower heart deaths.